Posted on by

The goals of this project will be achieved by the scientific and technological developments in both the medical and technological fields, as detailed by the following three strongly correlated S&T sub-objectives:

  • Find new biomarkers and define a suitable multimodal paradigm with already available PET, MR, EEG and PET/MR systems that provides clinical evidence on the feasibility of advanced schizophrenia diagnosis.
  • Construct and test an optimized cost-effective trimodality imaging instrument (brain PET/MR/EEG) for diagnosis, monitoring and follow-up of schizophrenia disorders.
  • Validate the trimodal imaging device built by this Consortium with regard to the results and the clinical data obtained from objective 1.